T3 · Product exporter position

Finland exports of Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale (HS 300490)

See where Finland stands in medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.

Exporter FINHS6 300490Latest year 2024Rapid growth

Latest exports

$1.9BLatest observed lane total

Destination markets

113Reported active markets

Three-year growth

+33.2%Annualized change

Destination HHI

2,379Destination concentration

Weighted share

0.8%Reported market position

Exporter evidence

How strong is Finland in Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale?

Reported exporter totals and calculated indicators for HS 300490. Values retain their observed coverage period.

Exporter scale

Latest exports$1.9B
Current 2024 exports$1.9B
Three-year average$1.4B
Historical peak$2.6B

Market position

Active destinations113
Destination HHI2,379
Weighted share0.8%
Share change+0.2 pp

Competitiveness

Three-year growth+33.2%
Volatility1.2
Maximum drawdown74.6%
TrendRapid growth
MeasureValueWhat it describes
ExporterFinlandCountry represented by this profile
Latest observed exports$1.9BSum of latest observed destination-lane values
Current 2024 exports$1.9BCommon-year comparison where reported
Three-year growth+33.2%Annualized change in exporter totals
Five-year growth+26.5%Annualized change in exporter totals
Leading destinationUSADestination with the largest observed export value
Leading destination share47.2%Share of observed exporter totals
Destination concentration2,379HHI across destination markets
Weighted share change+0.2 ppValue-weighted latest change in market share
Limited-history lanes18%Share of lanes with shorter history

Destination markets

Where does Finland sell medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
USA, Puerto Rico and US Virgin Islands$897.2M1.2%+73.9%0% tariffAccelerating

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports
$897.2M
Market share
1.2%
Growth
+73.9%
Access
0% tariff
Signal
Accelerating

Price intelligence

How does Finland's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Switzerland, Liechtenstein: $77.1M / ton.

Lowest reported price

Ireland: $3.1K / ton.

Median price

$274.5K / ton across reported markets.

Export trend

Reported export history

Annual observations for Finland and HS 300490 where available.

YearExportsYear-on-year changeActive destinations
2010$967.3M-0.9%114
2011$1.1B+15.1%116
2012$1.1B-5.6%117
2013$822.8M-21.7%120
2014$742.5M-9.8%115
2015$669.9M-9.8%115
2016$644.2M-3.8%122
2017$628.4M-2.5%122
2018$656.2M+4.4%117
2019$587.1M-10.5%121
2020$703.7M+19.9%131
2021$803.1M+14.1%129
2022$867.9M+8.1%112
2023$1.4B+62%123
2024$1.9B+35.1%113

Exporter context

Finland economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300490.

Finland has reported exports of $77.2B and a trade balance of $2.4B in 2024.

Available structural indicators include 52.9% trade openness, 23.3% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Finland medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.